𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dopaminergic medication boosts action–effect binding in Parkinson's disease

✍ Scribed by James W. Moore; Susanne A. Schneider; Petra Schwingenschuh; Giovanna Moretto; Kailash P. Bhatia; Patrick Haggard

Book ID
113819792
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
466 KB
Volume
48
Category
Article
ISSN
0028-3932

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The DRD2 TaqIA polymorphism and demand o
The DRD2 TaqIA polymorphism and demand of dopaminergic medication in Parkinson's disease
✍ Sebastian Paus; Anne Grünewald; Christine Klein; Michael Knapp; Alexander Zimpri 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB 👁 1 views

## Abstract Previous studies have demonstrated that the __TaqIA__ polymorphism of the D2 dopamine receptor gene (__DRD__2) is associated with response to dopaminergic and antidopaminergic treatment in Parkinson's disease (PD) and schizophrenia, respectively. We tested whether the __TaqIA__ genotype